Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
FDA clears Bristol Myers cancer drug from Turning Point buy
Compared with Pfizer's Xalkori and Roche's Rozlytrek, BMS' Augtyro has shown the best tumor response data in ROS1-positive lung cancer.
Angus Liu
Nov 16, 2023 11:10am
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
Capturing COVID: Biopharma through the lens during the pandemic
Nov 13, 2023 7:45am
With high-dose Eylea launch, Regeneron eyes battle with Roche
Nov 2, 2023 11:44am
Genentech, ADA launch new 'eye pledge'
Oct 31, 2023 10:00am
Roche's Vabysmo snares FDA nod to treat retinal vein occlusion
Oct 27, 2023 11:07am
